Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

NCT01614912 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SM-13496

Sponsor

Sumitomo Pharma Co., Ltd.